BPS Survey: Vaccine Hesitancy Due to Concerns Over Side Effects
- A Small Font
- A Medium Font
- A Bigger Font
Indonesia's COVID-19 vaccination program has only reached 93% for the first dose and 79% for the second dose. A significant portion of the population remains unvaccinated due to various reasons.
A February 2022 survey by the Central Statistics Agency (BPS) revealed that 19.5% of respondents were unwilling to be vaccinated due to concerns about side effects.
Furthermore, 9.2% of respondents were hesitant due to a lack of confidence in the vaccine's effectiveness. 6.4% of respondents had not been vaccinated because they were waiting for their scheduled vaccination.
Additionally, 4.9% were still searching for vaccination sites with available quotas. Finally, 60.1% cited other reasons, such as health factors, pregnancy, inadequate facilities and infrastructure, and other miscellaneous reasons.
The survey, conducted from February 16th to 25th, 2022, involved 254,817 respondents. It employed a non-probability snowball sampling design.
"Disclosure: This is an AI-generated translation of the original article. We strive for accuracy, but please note that automated translations may contain errors or slight inconsistencies."
Related Data
Latest Data Stories
Trending Topics
Popular Data